Aurora Cannabis Valuation Multiples

Discover Aurora Cannabis' revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like TerrAscend, Cresco Labs, High Tide, SNDL and more.

Aurora Cannabis Overview

About Aurora Cannabis

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.


Founded

2006

HQ

Canada

Employees

1.1K

Financials (LTM)

Revenue: $222M
EBITDA: $28M

EV

$201M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Aurora Cannabis Financials

Aurora Cannabis reported last 12-month revenue of $222M and EBITDA of $28M.

In the same LTM period, Aurora Cannabis generated $110M in gross profit, $28M in EBITDA, and had net loss of ($31M).

Revenue (LTM)


Aurora Cannabis P&L

In the most recent fiscal year, Aurora Cannabis reported revenue of $231M and EBITDA of ($33M).

Aurora Cannabis is unprofitable as of last fiscal year, with gross margin of 43%, EBITDA margin of (14%), and net margin of (42%).

See analyst estimates for Aurora Cannabis
LTMLast FY202320242025202620272028
Revenue$222M$231M$178M$234M$235M
Gross Profit$110M$98M$71M$125M$108M
Gross Margin50%43%40%53%46%
EBITDA$28M($33M)($35M)$26M($13M)
EBITDA Margin13%(14%)(20%)11%(5%)
EBIT Margin(11%)(15%)(24%)0%(10%)
Net Profit($31M)($98M)($73M)($12M)($73M)
Net Margin(14%)(42%)(41%)(5%)(31%)
Net Debt-($42M)---

Financial data powered by Morningstar, Inc.

Aurora Cannabis Stock Performance

Aurora Cannabis has current market cap of $257M, and enterprise value of $201M.

Market Cap Evolution


Aurora Cannabis' stock price is $4.06.

Aurora Cannabis share price decreased by 31.6% in the last year.

Aurora Cannabis has an EPS (earnings per share) of $-1.55.

See more trading valuation data for Aurora Cannabis
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$201M$257M0.9%-45.4%-31.6%$-1.55

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Aurora Cannabis Valuation Multiples

Aurora Cannabis trades at 0.9x EV/Revenue multiple, and 7.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Aurora Cannabis

EV / Revenue (LTM)


Aurora Cannabis Financial Valuation Multiples

As of September 1, 2026, Aurora Cannabis has market cap of $257M and EV of $201M.

Aurora Cannabis has a P/E ratio of (8.3x).

LTMLast FY202320242025202620272028
EV/Revenue0.9x0.9x1.1x0.9x0.9x
EV/EBITDA7.2x(6.0x)(5.7x)7.9x(15.9x)
EV/EBIT(8.2x)(6.0x)(4.7x)n/m(8.6x)
EV/Gross Profit1.8x2.0x2.8x1.6x1.9x
P/E(8.3x)(2.6x)(3.5x)(22.1x)(3.5x)
EV/FCF(8.9x)(9.2x)(2.9x)(11.9x)(10.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Aurora Cannabis Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Aurora Cannabis Margins & Growth Rates

Aurora Cannabis decreased revenue by 8% and EBITDA by 143% in the last fiscal year.

In the most recent fiscal year, Aurora Cannabis reported gross margin of 43%, EBITDA margin of (14%), and net margin of (42%).

See estimated margins and future growth rates for Aurora Cannabis

Aurora Cannabis Margins

Last FY202420252026202720282029
Gross Margin43%53%46%49%
EBITDA Margin(14%)11%(5%)1%
EBIT Margin(15%)0%(10%)(7%)
Net Margin(42%)(5%)(31%)(17%)
FCF Margin(9%)(7%)(9%)(8%)

Aurora Cannabis Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(8%)32%0%(8%)
Gross Profit Growth11%76%(14%)(1%)
EBITDA Growth(143%)(172%)(150%)(119%)
EBIT Growth(75%)(101%)(4668%)(37%)
Net Profit Growth(84%)(84%)529%(50%)
FCF Growth(25%)(76%)18%(11%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Aurora Cannabis Operational KPIs

Aurora Cannabis' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Aurora Cannabis' Rule of 40 is (7%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Aurora Cannabis' Rule of X is (19%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Aurora Cannabis
LTMLast FY202320242025202620272028
Rule of 4012%(7%)---
Bessemer Rule of X11%(19%)---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue17%19%20%17%18%
G&A Expenses to Revenue32%33%41%33%35%
R&D Expenses to Revenue1%1%2%1%1%
Opex to Revenue-57%64%53%56%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Aurora Cannabis Competitors

Aurora Cannabis competitors include TerrAscend, Cresco Labs, High Tide, SNDL, Organigram Global, Cannara Biotech, Grown Rogue International, Jushi Holdings, Ispire Technology and Ascend Wellness Holdings.

Most Aurora Cannabis public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
TerrAscend1.8x1.7x7.8x6.7x
Cresco Labs1.1x1.1x45.4x5.0x
High Tide0.7x0.6x(32.0x)8.1x
SNDL0.5x0.5x11.3x8.1x
Organigram Global1.2x0.9x(15.7x)9.2x
Cannara Biotech2.0x1.7x7.5x6.6x
Grown Rogue International4.1x-15.1x-
Jushi Holdings1.4x1.3x9.5x7.2x

This data is available for Pro users. Sign up to see all Aurora Cannabis competitors and their valuation data.

Start Free Trial

Acquisitions by Aurora Cannabis

Aurora Cannabis has acquired 17 companies to date.

Last acquisition by Aurora Cannabis was on August 19th 2026. Aurora Cannabis acquired HAP Pharma for $3M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Aurora Cannabis

HAP Pharma
Internode Pharma
Safari Flower Company
MedReleaf Australia
Description
HAP Pharma is a distributor focused on medical cannabis products and treatments.
Internode Pharma is a UK-focused distributor and logistics partner for medical cannabis, handling regulatory import, warehousing, and last-mile fulfillment to pharmacies and patients across the licensed therapeutic market.
Safari Flower Company is a micropropagation lab that cultivates cannabis plants.
-
HQ CountryUnited KingdomUnited KingdomCanadaAustralia
HQ City
Birmingham
Birmingham
Stevensville, MD
-
Deal Date19 Aug 202619 Aug 202614 Apr 20268 Feb 2024
Valuation$3M$3M$27M$36M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Aurora Cannabis acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Aurora Cannabis

Aurora Cannabis has invested in 4 companies to date.

Latest investment by Aurora Cannabis was on November 8th 2021. Aurora Cannabis invested in Growery in their Strategic investment round.

See VC round multiples

Latest Investments by Aurora Cannabis

Growery
High Tide
Capcium
The Green Organic Dutchman Holdings
Description
Growery is a cannabis cultivation and supply company participating in the Dutch government's controlled supply chain experiment. Located in the Netherlands, it grows, processes, and delivers recreational cannabis to licensed coffee shops in cities like Breda and Tilburg. Growery adheres to strict quality and traceability standards under the national pilot program launched in 2023.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.
Capcium is a Kelowna-based provider of softgel encapsulation services for the Canadian cannabis sector. The company produces high-potency cannabinoid-infused capsules for licensed producers using pharmaceutical-grade equipment. Its processes ensure precise dosing and bioavailability through lipid-based formulations. Capcium leverages 30 years of nutraceutical expertise to supply products compliant with Health Canada regulations. Operations include in-house R&D for custom formulations and scalability to meet demands from producers like Aurora Cannabis.
The Green Organic Dutchman Holdings Ltd. is a licensed medical cannabis producer based in Ancaster, Ontario, Canada. It cultivates organic cannabis at facilities in Ontario and Quebec under ACMPR regulations, adhering to sustainable principles with lab-tested products. The company lists its shares on the TSX as TGOD and maintains a strategic partnership with Aurora Cannabis Inc., expanding production capacity through tgod.ca.
HQ CountryNetherlandsCanadaUnited StatesCanada
HQ City
Amsterdam
Calgary
St Louis, MO
Hamilton
Deal Date8 Nov 202113 Dec 20187 Jun 20181 Feb 2018
RoundStrategic investmentSeries AStrategic investmentUndisclosed stage
Raisedundisclosed$10M$10M$23M
InvestorsAurora CannabisAurora CannabisAurora CannabisAurora Cannabis
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Aurora Cannabis investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Aurora Cannabis

When was Aurora Cannabis founded?Aurora Cannabis was founded in 2006.
Where is Aurora Cannabis headquartered?Aurora Cannabis is headquartered in Canada.
How many employees does Aurora Cannabis have?As of today, Aurora Cannabis has over 1K employees.
Who is the CEO of Aurora Cannabis?Aurora Cannabis' CEO is Miguel Martin.
Is Aurora Cannabis publicly listed?Yes, Aurora Cannabis is a public company listed on Toronto Stock Exchange.
What is the stock symbol of Aurora Cannabis?Aurora Cannabis trades under ACB ticker.
When did Aurora Cannabis go public?Aurora Cannabis went public in 2014.
Who are competitors of Aurora Cannabis?Aurora Cannabis main competitors include TerrAscend, Cresco Labs, High Tide, SNDL, Organigram Global, Cannara Biotech, Grown Rogue International, Jushi Holdings, Ispire Technology, Ascend Wellness Holdings.
What is the current market cap of Aurora Cannabis?Aurora Cannabis' current market cap is $257M.
What is the current revenue of Aurora Cannabis?Aurora Cannabis' last 12 months revenue is $222M.
What is the current revenue growth of Aurora Cannabis?Aurora Cannabis revenue growth (NTM/LTM) is (1%).
What is the current EV/Revenue multiple of Aurora Cannabis?Current revenue multiple of Aurora Cannabis is 0.9x.
What is the current EBITDA of Aurora Cannabis?Aurora Cannabis' last 12 months EBITDA is $28M.
What is Aurora Cannabis' EBITDA margin?Aurora Cannabis' last 12 months EBITDA margin is 13%.
What is the current EV/EBITDA multiple of Aurora Cannabis?Current EBITDA multiple of Aurora Cannabis is 7.2x.
What is the current FCF of Aurora Cannabis?Aurora Cannabis' last 12 months FCF is ($22M).
What is Aurora Cannabis' FCF margin?Aurora Cannabis' last 12 months FCF margin is (10%).
What is the current EV/FCF multiple of Aurora Cannabis?Current FCF multiple of Aurora Cannabis is (8.9x).
How many companies Aurora Cannabis has acquired to date?As of September 2026, Aurora Cannabis has acquired 17 companies.
What was the largest acquisition by Aurora Cannabis?$2.4B acquisition of MedReleaf on 14th May 2018 was the largest M&A Aurora Cannabis has done to date.
What companies Aurora Cannabis acquired?Aurora Cannabis acquired MedReleaf, CanniMed Therapeutics, ICC Labs, Whistler Medical Marijuana Corporation, Hempco, Anandia Labs, Bevo Agro, Reliva, CanvasRx Holdings, MedReleaf Australia, and 7 other companies.
In how many companies Aurora Cannabis has invested to date?As of September 2026, Aurora Cannabis has invested in 4 companies.
What was the last Aurora Cannabis investment?On 8th November 2021 Aurora Cannabis invested in Growery, participating in a Strategic investment round.
In what companies Aurora Cannabis invested in?Aurora Cannabis invested in The Green Organic Dutchman Holdings, High Tide, Capcium, and Growery.

See public comps similar to Aurora Cannabis

Lists including Aurora Cannabis

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial